As of March 23, 2026, Coya Therapeutics's top three insider holders are Dov A Md Goldstein (Director, 27.56K shares), Arun Swaminathan (Chief Executive Officer, 10.00K shares), Anabella Villalobos (Director, 10.00K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Dov A Md Goldstein | 27,557 | 0 | 19 Aug, 2025 | |
| Arun Swaminathan | Chief Executive Officer | 10,000 | 0 | 13 Nov, 2024 |
| Howard Berman | Chief Executive Officer | 10,000 | 0 | 04 Jan, 2023 |
| Anabella Villalobos | 10,000 | 0 | 04 Jan, 2023 | |
| Adrian Hepner | Chief Medical Officer | 10,000 | 0 | 04 Jan, 2023 |
| David S Snyder | Chief Financial Officer | 8,800 | 0 | 14 Nov, 2024 |
| Fred Grossman | Chief Medical Officer | 2,710 | 0 | 12 Nov, 2024 |
| Hideki Garren | 2,000 | 0 | 04 Jan, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 22 Jan, 2026 | Fred Grossman | Stock Option (right to buy) | A | 140,041 | $0.00 | 140,041 | D | A |
| 22 Jan, 2026 | Arun Swaminathan | Stock Option (right to buy) | A | 293,983 | $0.00 | 293,983 | D | A |
| 22 Jan, 2026 | David S Snyder | Stock Option (right to buy) | A | 140,041 | $0.00 | 140,041 | D | A |
| 22 Jan, 2026 | Howard Berman | Stock Option (right to buy) | A | 15,257 | $0.00 | 15,257 | D | A |
| 02 Jan, 2026 | Dov A Md Goldstein | Stock Option (right to buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 02 Jan, 2026 | Ann Lee | Stock Option (right to buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 02 Jan, 2026 | Dieter Weinand | Stock Option (right to buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 02 Jan, 2026 | Anabella Villalobos | Stock Option (right to buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 02 Jan, 2026 | Wilbur L Jr Ross | Stock Option (right to buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 18 Aug, 2025 | Dov A Md Goldstein | Common Stock, par value $0.0001 per share | A | 17,557 | $1.09 | 27,557 | D | M |
| 18 Aug, 2025 | Dov A Md Goldstein | Stock Option (right to buy) | D | 17,557 | $0.00 | 0 | D | M |
| 25 Feb, 2025 | Anabella Villalobos | Stock Option (right to buy) | A | 5,000 | $0.00 | 5,000 | D | A |
| 25 Feb, 2025 | Dov A Md Goldstein | Stock Option (right to buy) | A | 5,000 | $0.00 | 5,000 | D | A |
| 25 Feb, 2025 | Wilbur L Jr Ross | Stock Option (right to buy) | A | 5,000 | $0.00 | 5,000 | D | A |
| 25 Feb, 2025 | Dieter Weinand | Stock Option (right to buy) | A | 5,000 | $0.00 | 5,000 | D | A |
| 25 Feb, 2025 | Ann Lee | Stock Option (right to buy) | A | 5,000 | $0.00 | 5,000 | D | A |
| 09 Jan, 2025 | David S Snyder | Stock Option (right to buy) | A | 140,562 | $0.00 | 140,562 | D | A |
| 09 Jan, 2025 | Arun Swaminathan | Stock Option (right to buy) | A | 240,964 | $0.00 | 240,964 | D | A |
| 09 Jan, 2025 | Howard Berman | Stock Option (right to buy) | A | 150,602 | $0.00 | 150,602 | D | A |
| 09 Jan, 2025 | Fred Grossman | Stock Option (right to buy) | A | 140,562 | $0.00 | 140,562 | D | A |